Study Shows Seeing Sick Faces May Activate the Immune System
A recent study shows that participants who see sick-looking faces in virtual reality exhibit changes in brain activity related to personal space monitoring and threat detection, as well as an increase in the activity of certain immune cells in the blood.
Can Inverse Vaccines Cure Autoimmunity?
While traditional vaccines teach the immune system to fight off foreign invaders, inverse vaccines teach the immune system to ignore its own cells — and may completely reverse autoimmune disease.
Long COVID: Shedding Light on Other Viral Infections
The lingering effects of viral infections are not well-understood, but long COVID is helping shed light on the mysterious phenomenon, particularly in patients with chronic fatigue syndrome.
A Brief History of Immunity and Immunoglobulins
Discoveries about the types of immunity eventually led to the use of human antibodies to treat disease.
Emerging Novel Viruses
With trillions of viruses living in the human and other species’ microbiomes, the possibility of novel viruses such as COVID-19 emerging is high, but the threat they may pose is unknown.
Breakthroughs in Stem Cell Research
Optimism continues to grow about the use of stem cells in regenerative medicine highlighted by hundreds of successful clinical trials.
Tailor-Made Medicine: An Evolution in Precision Cures
With big data and artificial intelligence, there is great hope for tailor-made medicine, but there are challenges that must be overcome.
Nutrigenomics: How Genes and Nutrition Interact
Using nutrition to benefit health through the care and feeding of genes, though still in its infancy, is an exciting field of study seeing exponential growth.
Update on Conventional vs. DNA Vaccines
DNA vaccine technology has shown early promise in helping to fight some cancers, but no human DNA vaccines are yet approved for use.
Biosimilars: From Concept to Reality
Approvals in 2018 brought the total number of U.S. Food and Drug Administration-licensed biosimilars well into the double digits — and more are in the pipeline.